Each year over 234,000 new cases of prostate cancer are diagnosed in the U.S. Treatment options include surgery, radiation therapy, hormone therapy, “watchful waiting” and cryotherapy. Treatment depends on factors including the […]
[Video Profile] Interview with Ron Andrews, President & CEO of Clarient
Clarient provides access to technologies and services for the characterization, assessment and treatment of cancer. The company offers a full range of diagnostic technologies and services for the clinical cancer diagnostics industry […]
Rockland Technimed: Tissue Viability Imaging
Early detection of ischemic injury, though difficult to achieve, is becoming increasingly critical to the proper utilization of new interventional procedures. Experts note that although Magnetic Resonance Angiography can evaluate vessel anatomy […]
Investors Commit $30M to Rare-Cell Detection Tests
Ikonisys, a New Haven, CT, company that makes cell-based diagnostics for women’s health and oncology, has closed $30 million in Series E funding. The financing follows FDA clearance of two diagnostic applications […]
Endocare Raises $7 Million
Endocare, an Irvine, CA-based company focused on tissue and tumor ablation, has raised $7 million in a private placement of common stock to Seattle-based Frazier Healthcare Ventures. In a statement, Endocare CEO Craig […]
